搜尋結果
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Reuters· 3 日前Amylyx Pharmaceuticals has agreed to buy the rights to bankrupt drugmaker Eiger ...
Argenx’s Vyvgart Shot Gains US Approval for Rare Nerve Disorder
Bloomberg· 3 日前Argenx SE’s Vyvgart Hytrulo shot gained US approval to treat a rare nervous system disorder, a ...
US FDA approves Roche's drug for a chronic blood disorder
Reuters· 4 日前, opens new tab drug for a chronic blood disorder, the Swiss drugmaker said. The drug ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 4 日前If cleared by the Food and Drug Administration...as we can" at the beginning of 2025, ...
Pitch Deck Teardown: Feel Therapeutics' $3.5M seed deck
TechCrunch· 4 日前Feel Therapeutics is working to make mental health care more science-forward. The company makes wearable devices, mobile ...
Stronger health awareness awakens sleep economy
China Daily· 4 日前Zhang Min, a post-95s white-collar worker who has been suffering from insomnia for three years, averages a sleep time of ...
Council Post: The Evolution Of AI And Mental Healthcare
Forbes· 4 日前People have been using chatbots for decades, well before ChatGPT was released. One of the first chatbots was created < ...
Social media fueling suicide epidemic in US
China Daily· 4 日前In times of disinformation, deep fakes and artificial intelligence that have further blurred the lines ...
This little-known biotech stock is primed to surge nearly 50%, Canaccord says
CNBC· 5 日前"We view these data as even more impressive as they are very consistent with the recent ...
Council Post: What Is The Business Microbiome Of Your Organization?
Forbes· 5 日前Michael Dennis is Vice President, Legal, PMO and Innovation for CAS. Have you ever thought of ...